Icon ArrowBack
Bio Usawa Celebrates Scientific Advisory Board Member Nazik Hammad, MD, MSc, MEHP, FACP for Receiving SCO’s Conquer Cancer Foundation Award

June 2, 2025 Kigali, Rwanda and San Francisco, USA

Bio Usawa is proud to celebrate its Scientific Advisory Board Member, Dr. Nazik Hammad, MD, MSc, MEHP, FACP for receiving the Conquer Cancer (The ASCO Foundation)’s International Women Who Conquer Cancer Mentorship Award at this year’s annual ASCO meeting in Chicago, IL. Conquer Cancer’s grants and awards, totaling more than $11.5 MUSD this year, support oncology professionals at every career stage to help accelerate breakthroughs in research across the globe. Dr. Hammad, an internationally known oncologist specializing in breast and GI cancers at University of Toronto’s St. Michael Hospital, received the Mentorship award in recognition of her tireless contributions to faculty and workforce development in Africa. She is also Chair of the African Organization for Research and Training in Cancer (AORTIC) Significant Interest Group in Cancer in Conflict Zones and other Humanitarian settings. Congratulations, Dr. Hammad!

About Bio Usawa, Inc. (BUI)

Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.